legislation: 117-hr-9378
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117-hr-9378 | 117 | hr | 9378 | Sunshine Act of 2022 | Health | 2022-12-01 | 2022-12-01 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House | Rep. Burgess, Michael C. [R-TX-26] | TX | R | B001248 | 1 | Sunshine Act of 2022 This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. | 2023-08-04T17:00:41Z |